Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Purple Biotech Ltd. - American Depositary Shares
(NQ:
PPBT
)
1.462
-0.048 (-3.21%)
Delayed Quote
Updated: 9:50 AM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Purple Biotech Ltd. - American Depositary Shares
< Previous
1
2
3
4
5
6
Next >
Peraso (NASDAQ: PRSO) Eyes Military Robotics as U.S. Army Advances Autonomous Fleet
September 02, 2026
Via
AB Newswire
Topics
Artificial Intelligence
Intellectual Property
New U.S. Patent Allowance Strengthens Protection for CAPTN-3 Modular Platform for Next-Generation Multispecific Antibodies
September 02, 2026
From
Purple Biotech Ltd.
Via
GlobeNewswire
Top movers analysis one hour before the close of the markets on 2026-06-11: top gainers and losers in today's session.
↗
June 11, 2026
Via
Chartmill
Which stocks are experiencing notable movement on Thursday?
↗
June 11, 2026
Via
Chartmill
Traders are paying attention to the gapping stocks in Thursday's session.
↗
June 11, 2026
Via
Chartmill
Wondering what's happening in today's pre-market session?
↗
June 11, 2026
Via
Chartmill
Purple Biotech Presents New Preclinical Data at EACR 2026 Highlighting IM1240's Anti-Tumor Activity, Favorable Safety and Pharmacokinetic Profile, and Broad Therapeutic Window
June 11, 2026
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Announces New Data from CAPTN-3 Platform Tri-specific IM1240
April 27, 2026
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Establishes Scientific Advisory Board to Support Development of CAPTN-3 Tri-Specific Antibody Platform
April 23, 2026
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Announces AI Collaboration with Converge Bio to Accelerate Development of its Next-Generation Tri-Specific Antibody Platform
March 25, 2026
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Regains Compliance with Nasdaq
March 17, 2026
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Announces CEO Transition
March 13, 2026
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Announces Plan to Implement ADS Ratio Change
February 25, 2026
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Achieves Toxicology Milestone Demonstrating an Expanded Therapeutic Window for CAPTN-3 Platform Tri-specific Antibody, IM1240
January 07, 2026
From
Purple Biotech Ltd.
Via
GlobeNewswire
Get insights into the top gainers and losers of Tuesday's after-hours session.
↗
December 16, 2025
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
Purple Biotech Reports Positive New Preclinical Data Demonstrating Multi-Arm Anti-Tumor Activity Across Two CAPTN-3 Tri-Specific Antibodies at ESMO Immuno-Oncology Congress 2025
December 11, 2025
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech to Present New Preclinical Data from its CAPTN-3 Tri-Specific Antibody Platform at the European Society of Medical Oncology Immuno-Oncology (ESMO-IO) 2025 Annual Congress
December 04, 2025
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Reports Third Quarter 2025 Financial Results and Provides Business Update
November 14, 2025
From
Purple Biotech Ltd.
Via
GlobeNewswire
What's going on in today's after hours session
↗
November 07, 2025
The US market regular session of Friday is over, let's have a look at the top gainers and losers in the after hours session today.
Via
Chartmill
12 Health Care Stocks Moving In Friday's After-Market Session
↗
November 07, 2025
Via
Benzinga
Get insights into the top gainers and losers of Thursday's pre-market session.
↗
October 30, 2025
The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
October 30, 2025
Via
Benzinga
Why Alphabet Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
↗
October 30, 2025
Via
Benzinga
Curious about the most active stocks on Wednesday?
↗
October 29, 2025
Wednesday's session is buzzing with activity. Check out the stocks that are attracting the most attention and driving market activity!
Via
Chartmill
Keep an eye on the top gainers and losers in Wednesday's session.
↗
October 29, 2025
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
October 29, 2025
Via
Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
October 29, 2025
The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via
Chartmill
Dow Surges 250 Points; Verizon Posts Mixed Q3 Results
↗
October 29, 2025
Via
Benzinga
Topics
Stocks
Purple Biotech Shares Soar 92% On Breakthrough For Experimental Cancer Drug
↗
October 29, 2025
Purple said that it has achieved a commercially viable yield for IM1240, positioning the program competitively for future development.
Via
Stocktwits
Get insights into the top gainers and losers of Wednesday's pre-market session.
↗
October 29, 2025
Before the opening bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via
Chartmill
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
